In short
Polymyalgia rheumatica is an inflammatory condition that brings sudden pain and stiffness to the shoulders, neck, and hips, most commonly affecting people over the age of 65. While the exact cause remains unclear, the condition can dramatically disrupt daily life—but with proper treatment, most people find meaningful relief within days.
Key points
- Polymyalgia rheumatica almost exclusively affects people over 50, with the highest rates occurring between ages 70 and 75, and it's more than twice as common in women.
- Symptoms often appear suddenly—sometimes literally overnight—with severe morning stiffness lasting more than 45 minutes in the shoulders, neck, and hips.
- The exact cause remains unknown, but researchers believe a combination of genetic susceptibility and environmental triggers like infections may be responsible.
- Between 10% and 20% of people with PMR develop giant cell arteritis, a serious condition requiring immediate treatment to prevent blindness or stroke.
- Low-dose corticosteroids like prednisone can relieve symptoms within days, sometimes after just one dose, making the response to treatment remarkably fast.
- Unlike many types of arthritis, polymyalgia rheumatica doesn't cause visible joint swelling, which can make diagnosis challenging.
- Most people need steroid treatment for 12 months to 2 years, with doses gradually reduced over time as symptoms stay controlled.
- Staying active with gentle exercise like walking, swimming, or yoga can help manage stiffness and prevent the condition from worsening, despite the pain.
Epidemiology
Polymyalgia rheumatica, often called PMR, is more common than many people realize. In the United States, it affects approximately 50 out of every 100,000 people each year. The condition primarily strikes older adults and is very rare in people younger than 50 years of age. Most people who receive a diagnosis are over 65, with the highest rates occurring between ages 70 and 75.
When looking at who gets polymyalgia rheumatica, clear patterns emerge. Women experience this condition more frequently than men—they are more than twice as likely to develop it. Race and ethnic background also play a significant role. Caucasian people, especially those of Northern European or Scandinavian ancestry, develop PMR much more often than any other racial or ethnic group. The condition is rare in other populations.
Causes
Despite decades of research, the exact cause of polymyalgia rheumatica remains unknown. Scientists believe that the condition likely results from a combination of genetic and environmental factors working together. This means that some people may be born with genes that make them more vulnerable to developing PMR, but something in their environment needs to trigger the condition.
Research has identified certain genetic patterns associated with PMR. One of the most important findings involves HLA class II alleles, which are variations in genes that help control the immune system. Among these, the HLA-DRB1*04 allele appears most frequently in people with polymyalgia rheumatica, showing up in as many as 67% of cases. Other genetic variations affecting proteins like ICAM-1, RANTES, and IL-1 receptors also seem to play a role in some populations.
Environmental triggers are also suspected. During epidemics of mycoplasma pneumonia and parvovirus B19 in Denmark, researchers noticed an increased number of people developing PMR and its related condition, giant cell arteritis. This pattern suggests that infections might trigger the disease in people who are genetically susceptible. Some research has also identified possible associations with the seasonal flu vaccine and, more controversially, with COVID-19 vaccination, though the evidence remains debated. A few cases have occurred after specific cancer treatments.
Some researchers theorize that polymyalgia rheumatica might be an autoimmune disease, meaning the body's immune system mistakenly attacks its own tissues. Others believe the inflammation might come from inflamed fluid-filled sacs called bursae in the shoulders or hips. However, none of these theories has been definitively proven.
Risk Factors
Understanding who is most at risk for polymyalgia rheumatica can help with early recognition. Age stands out as the most important risk factor. The condition almost exclusively affects people over 50 years old, and the risk continues to increase with each passing year. By the time people reach their 70s, particularly between ages 70 and 75, they face the highest risk of all.
Being female increases the likelihood of developing PMR. Women are diagnosed with this condition more than twice as often as men, though researchers don't fully understand why. Changes in hormone levels might play a role, but this explanation doesn't account for all the gender differences seen in the disease.
Ethnic background matters significantly. People of Northern European descent, particularly those with Scandinavian ancestry, experience polymyalgia rheumatica far more frequently than people from other parts of the world. White adults generally face higher rates of PMR compared to other racial groups.
Symptoms
The symptoms of polymyalgia rheumatica typically appear suddenly—sometimes developing overnight or within just a few days or weeks. Many people can remember the exact moment when they first noticed something was wrong. The hallmark symptom is muscle stiffness, particularly in the morning, that lasts longer than 45 minutes. This stiffness can be so severe that it makes getting out of bed feel nearly impossible.
Pain and stiffness usually affect both sides of the body at the same time. The most commonly affected areas include the shoulders, neck, upper arms, hips, thighs, and buttocks. The lower back can also be involved. People often describe the pain as aching rather than sharp. While the discomfort is usually worse in the morning, it tends to improve somewhat as the day progresses and with gentle activity. However, after long periods of inactivity—like sitting through a movie or taking a long car ride—the stiffness returns with a vengeance.
The impact on daily life can be profound. Many people with polymyalgia rheumatica struggle with simple tasks they once took for granted. Getting dressed becomes a challenge, especially activities that require raising the arms, like putting on a jacket or brushing hair. Pulling on socks and shoes can be difficult when bending over causes pain. Raising arms above the shoulders may be particularly troublesome. Getting up from a low chair or sofa, climbing in and out of a car, and turning over in bed can all become painful ordeals.
Beyond the muscle and joint symptoms, polymyalgia rheumatica can cause other problems throughout the body. Many people experience extreme tiredness or fatigue that doesn't improve with rest. Loss of appetite is common, often leading to unintentional weight loss. Some people run mild fevers. A general sense of feeling unwell, called malaise, can persist. Feeling depressed or down is not uncommon given the physical limitations the condition imposes. Some people notice swelling in their hands or wrists. These additional symptoms help distinguish PMR from other conditions that cause muscle pain.
Prevention
Unfortunately, because the exact cause of polymyalgia rheumatica is not known, there are no proven ways to prevent the condition from developing. Unlike some diseases where lifestyle changes or vaccines can reduce risk, PMR appears to strike without clear warning signs or preventable triggers. The genetic and environmental factors that contribute to its development are not things people can easily control or avoid.
However, this doesn't mean people are entirely powerless. Early recognition and prompt treatment can prevent many of the complications associated with PMR. If you're over 50 and experience new onset of pain and stiffness that lasts more than a week, especially if it's worse in the morning and affects your shoulders and hips, seeing a doctor quickly is important. Early diagnosis means earlier treatment, which can prevent the loss of mobility and the impact on daily activities that untreated PMR can cause.
For people already diagnosed with polymyalgia rheumatica, being vigilant about symptoms of giant cell arteritis serves as an important form of secondary prevention. Watching for warning signs like new or persistent headaches, jaw pain when eating or talking, scalp tenderness, or any vision changes—including double vision, blurred vision, or vision loss—allows for immediate medical intervention if giant cell arteritis develops. Quick treatment of giant cell arteritis can prevent serious complications like permanent blindness or stroke.
Pathophysiology
Polymyalgia rheumatica is fundamentally an inflammatory condition, meaning it involves the body's immune response becoming overactive in certain areas. The inflammation primarily affects the large muscle groups around the shoulders, neck, and hips, though researchers continue to debate exactly where this inflammation occurs and what triggers it.
One of the key findings in people with PMR is elevated levels of inflammatory markers in the blood. Two tests commonly show abnormal results: the erythrocyte sedimentation rate (also called ESR or sed rate) and C-reactive protein (CRP). Both of these measure inflammation happening somewhere in the body. When inflammation is present, certain proteins appear in higher amounts in the bloodstream, and these tests detect them. Most people with polymyalgia rheumatica have elevated ESR and CRP levels, though not everyone does, which can make diagnosis tricky.
Some researchers believe the pain in polymyalgia rheumatica comes from inflammation of the bursae—small, fluid-filled sacs that cushion the joints, particularly in the shoulders and hips. When these bursae become inflamed, a condition called bursitis, they can cause pain and stiffness similar to what people with PMR experience. This theory helps explain why the pain localizes to specific large joints rather than affecting muscles throughout the entire body.
The connection between polymyalgia rheumatica and giant cell arteritis provides additional clues about the underlying disease process. Some experts consider these two conditions part of the same disease spectrum rather than separate problems. In giant cell arteritis, inflammation affects the walls of medium and large blood vessels, particularly the temporal arteries in the head and the aorta. When this happens alongside or after PMR, it suggests that the inflammatory process can spread beyond the areas around joints to involve blood vessels as well. This overlap has led researchers to think about PMR as a systemic inflammatory disorder—one that affects multiple body systems—rather than just a localized joint problem.
The rapid response to steroid treatment offers another window into understanding the disease. When people with polymyalgia rheumatica take corticosteroids like prednisone, their symptoms often improve dramatically within days, sometimes even after a single dose. This quick response tells us that the inflammation driving PMR is very sensitive to these anti-inflammatory medications. Steroids work by blocking certain chemicals the body produces during the inflammatory response, essentially dampening down an overactive immune system. The fact that this approach works so well supports the idea that PMR fundamentally involves excessive inflammation that can be controlled when the right treatment is applied.
